Skip to main content
Equibles
OWLT logo

OWLT · Owlet, Inc.

Track OWLT — free

Use OWLT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OWLT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.28 +0.12 (+2.88%) At close · Oct 20
Rebalance outlook locked
Going-concern doubt — cleared Aug 14, 2026

The latest filing states the doubt was alleviated.

“In accordance with ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements included in this quarterly report on Form 10-Q are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$121.56M
Shares
29.22M
Volume · Oct 20 127.24K Avg daily vol (3M) 188.27K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.28 Open$4.10 Day$4.10–4.36 52W close$4.11–16.52 Avg vol 30d173K Short int606K · 2.1% float · 3.1d Short vol57% Last earningsAug 11, 2026 DataNov 2020–Oct 2026 Filing10-Q · Aug 14

Up next

Next earnings call
Nov 16, 2026 Est · unconfirmed · in 4 wks
Latest filing: 10-Q
filed Aug 14, 2026
Q2 2026 earnings call transcript
call held Aug 11, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$114.86M
Trailing 12 months
Net income (TTM)
−$8.81M
Trailing 12 months
Revenue growth YoY
+29.9%
Year over year
Operating margin
-6.3%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-7.1%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$13.88M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+81.4%
Year over year · more shares
Price change (1Y)
-51.9%
Trailing year
Short interest
2.1%
Latest settlement · 3.1 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▲140.9% $22.12M −$5.61M '24 Q3 ▼5.6% $19.84M −$9.22M '24 Q4* ▲46.1% $21.55M $3.53M '25 Q1 ▲25.9% $26.06M −$37.41M '25 Q2 ▲44.6% $31.99M $4.19M '25 Q3 ▲33.9% $26.55M −$9.14M '25 Q4* ▲4.2% $22.46M −$3.25M '26 Q1 LATEST ▲29.9% $33.87M −$620,000 '26 Q2

* Q4 derived as the full year minus Q1 to Q3.

AI Brief

Q2 FY26 earnings call · Aug 11, 2026
Q2 FY26

TL;DR. Owlet delivered record Q2 revenue and subscription growth, and raised full-year gross-margin and adjusted-EBITDA guidance largely to reflect a one-time tariff refund. It retained full-year revenue guidance while cautioning that Q3 revenue will decline sequentially and year over year amid aggressive discounting and tougher comparisons.

Bullish
  • + Q2 revenue reached a record $33.9 million, up 29.9% year over year.
  • + Subscription revenue rose to a record $3.2 million, up $2.4 million year over year.
  • + Underlying Q2 gross margin expanded to 54.0%, up 270 basis points year over year.
  • + Full-year gross-margin guidance increased to 53%–55% from 50%–52%.
  • + Full-year adjusted-EBITDA guidance increased to $10.75–$12.75 million from $7–$9 million.
Bearish
  • − Q3 revenue is expected to decline both sequentially and year over year.
  • − Aggressive competitor discounting and cautious consumer spending are pressuring near-term sales.
  • − Prime Day units sold declined 8% versus the prior-year event.
  • − Operating expenses increased to $20.1 million from $15.1 million.
  • − Full-year guidance improvements were driven only by the one-time tariff refund, leaving underlying expectations essentially unchanged.
  • − Average subscriber use remains about 12 months, below the company's at-least-two-year objective.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 17.3 · elevated Equity put/call 0.56
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −37%
below
Price vs 50-day avg −15%
below
RSI (14) 36
neutral
MACD trend Negative
52-week position 1%
near low
Momentum
relative strength
Very Weak
1-month return −23%
trailing
6-month return −12%
trailing
YTD return −74%
this year
Relative strength −20%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $5 › 200d $7 — 200d above 50d
Institutional flow Distributing
2 of 60 funds reported for Sep 30 · net -76.0K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.07% of float · ▲ +10.4% MoM · 3.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
60 holders — mid 3-yr range
Squeeze score 51
elevated · 0–100
Fundamentals
Strong
Revenue growth +37%
Y/Y
Gross margin 51%
expanding
EPS growth −43%
Y/Y
Free cash flow $-11.1M
Balance sheet $22.4M
net cash
Quant / Vol
risk profile
Very High
Volatility 83%
annualized · 1-yr
Max drawdown −75%
past year
ATR 5.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 2 of last 2
Latest guidance · from the Earnings Call filed Aug 11, 2026
full year 2026
Revenue outlook Maintained $118M – $122M
May 7, 2026 $118M – $122M changed to Aug 11, 2026 $118M – $122M
prior FY $106.16M midpoint +13.0% Y/Y
full year
Gross margin 53% – 55%
Prior guidance period ended · from the 8-K filed Mar 5, 2026
Revenue · first quarter of 2026 $20M – $21M
Gross margins · first quarter of 2026 50% – 52%
Adjusted EBITDA · first quarter of 2026 $-2.5M – $-1.5M
Guided vs delivered · last 2 settled
Revenue first quarter of 2026
guided $20M – $21M
$22.46M Beat +9.5%
Revenue full year 2025
guided $103M – $106M
$106.16M Beat +1.6%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−37% Bearish
Price vs 50-day avg
−15% Bearish
RSI (14)
36 Neutral
MACD trend
Negative Bearish
52-week position
1% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $5 › 200d $7 — 200d above 50d
Institutional flow Distributing
2 of 60 funds reported for Sep 30 · net -76.0K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
2.07% of float · ▲ +10.4% MoM · 3.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
60 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $4 Now $4 · 1% Range high $17
vs 200-day avg -37% vs 50-day avg -15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $6.7M the second quarter of 2026 —
Adjusted EBITDA excluding tariff refund impact non-GAAP $2.9M the second quarter of 2026 —
Adjusted net income per share non-GAAP $0.2 the second quarter of 2026 —
Non-GAAP adjusted net income (loss) non-GAAP $3.3M Six Months Ended June 30, 2026 —
Non-GAAP adjusted net income (loss) per share non-GAAP $0.12 Six Months Ended June 30, 2026 —
Subscription gross margin 68.4% the second quarter of 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OWLT
Owlet, Inc.
this stock
$121.56M -73.6% +37.1% — 2.1%
ABT
Abbott Laboratories
 $179.20B -18.2% +5.7% 33.3 0.8%
MDT
Medtronic plc
 $118.67B -1.5% +8.4% 22.9 3.1%
SYK
Stryker Corp
 $114.28B -13.4% +11.2% 30.9 1.5%
BSX
Boston Scientific Corp
 $66.02B -52.2% +12.5% 18.4 2.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
59
% held
58.3%
Reported
2 of 60
Top holder
ECLIPSE OPERATIONS, LLC
Held Float
View
Held by Funds
Fund positions
29
View
Short & Settlement
Short Interest Rising
Shares short
606.0K
Days to cover
3.1d
Change
+56.9K sh
View
Short Volume
Short vol %
57%
As of
Oct 20, 2026
Short Total
View
Fails to Deliver
FTD shares
19
Value
$95
As of
Sep 8, 2026
View
Off-Exchange
Off-exchange %
35.4%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$106.2M
Net income (FY)
$-38.8M
EPS diluted
$-2.27
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 14, 2026
This year
19
View
Proposed Sales
Value
$19.1K
Shares
5.0K
Filed
May 16, 2024
View
Earnings & Events
Webcasts
Last webcast
Aug 12, 2026
View
Investor Relations
Latest news
Owlet Launches Partnership with V…
Published
Oct 7, 2026
View

Performance

5D 20D 120D MTD YTD
OWLT -7.6% -22.6% -11.9% -18.6% -73.6%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -6.4% -22.0% -20.0% -19.5% -86.3%
Key facts CIK 1816708 CUSIP 69120X206 13F (30d) 2 filings 2 filers Visit website Investor relations